Molecular identification and differential proteomics of drug resistant Salmonella Typhi

Diagn Microbiol Infect Dis. 2023 Apr;105(4):115883. doi: 10.1016/j.diagmicrobio.2022.115883. Epub 2022 Dec 21.

Abstract

This study aimed to elucidate differentially expressed proteins in drug resistant Salmonella Typhi. Among 100 samples, S. typhi were identified in 43 samples. In drug susceptibility profile, 95.3% (41/43), 80% (35/43) and 70% (30/43) resistances were observed against Nalidixic acid, Ampicillin, and Chloramphenicol respectively. No resistance was observed against Imipenum and Azithromycin while only 11% (5/43) isolates were found resistant to Ceftriaxone. Mass spectrometric differential analysis resulted in 23 up-regulated proteins in drug resistant isolates. Proteins found up-regulated are involved in virulence (vipB, galU, tufA, and lpp1), translation (rpsF, rpsG, rplJ, and rplR), antibiotic resistance (zwf, phoP, and ompX), cell metabolism (metK, ftsZ, pepD, and secB), stress response (ridA, rbfA, and dps), housekeeping (gapA and eno) and hypothetical proteins including ydfZ, t1802, and yajQ. These proteins are of diverse nature and functions but highly interconnected. Further characterization may be helpful for elucidation of new biomarker proteins and therapeutic drug targets.

Keywords: Differential proteomics; Drug resistance; Mass spectrometry; S. Typhi.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Drug Resistance, Bacterial
  • Humans
  • Microbial Sensitivity Tests
  • Mitochondrial Proteins / therapeutic use
  • Proteomics
  • RNA-Binding Proteins / therapeutic use
  • Salmonella typhi* / genetics
  • Typhoid Fever* / drug therapy

Substances

  • Anti-Bacterial Agents
  • RBFA protein, human
  • RNA-Binding Proteins
  • Mitochondrial Proteins